Longbio Pharma & Dajin Debut on SEHK
05 Jun 2026
US$ 20.00
Longbio Pharma (Suzhou) Co Ltd (Longbio), backed by Highlight Capital, Qiming Venture Partners and Oriental Fortune...
Related Publications
Subscribers’ Weekly for the week ending 12 June 2026...
Peak XV Partners, through its seed investment platform, Surge, has led the US$5 m funding round in Hoola Health. The...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.